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ABSTRACT 
Objective: Today, nanotechnology has a variety of application areas. Pharmacy is one of the most important application fields of nanotechnology. 
Preparation of nano-particular drug-delivery system, such as nano-crystals improve the solubility and bio-availability of poorly water soluble drugs. 
Methods: Ziprasidone (ZIP) is a low water soluble drug (Bio-pharmaceutical classification system) and is used as a lipid regulating agent. In this 
study, a rapid and simple media milling method was used for the preparation of ziprasidone (ZIP) Nanocrystals. The use of sonication after media 
milling process reduced the milling time significantly. Different concentrations of stabilizers (Kollidone and Tween 80) were tested in the 
preparation of ZIP nanocrystals. The finest ZIP nanocrystals were obtained by 4 g ZIP, 4 g kollidone and 4 g Tween 80.  
Results: The size and zeta potential of the finest ZIP nanocrystals were 238.2±2.5 nm and-19.6±0.1 mv, respectively. The morphology of dried ZIP 
nanocrystals was observed using scanning electron microscopy. Differential scanning calorimetry of ZIP and ZIP nanocrystals confirmed that there 
was no interaction between ZIP and stabilizers. Compared with ZIP, the solubility of ZIP nanocrystals increased significantly. 
Conclusion: Media milling technology was successfully used for the formulation of poor water soluble drugs. Nano-sized drug particles prepared by 
media milling technique could improve the solubility and bio-availability of those drugs. 
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INTRODUCTION 
Approximately, 40% of newly discovered drugs show poor solubility 
in water [1].  The poor water solubility of drugs causes its poor bio-
availability [2]. There are many approaches to improve the solubility 
of poorly water soluble drugs. Some of these approaches include salt 
formation of drugs, use of co-solvents, surfactants and complexing 
agents [3]. Moreover, it has been reported that particle size reduction 
of drugs can increase the solubility of drugs [4]. Today, 
nanotechnology is an important tool to increase the solubility of poor 
water soluble drugs. The particle size reduction of these drugs to the 
nanometer range can improve their dissolution rate and bio-
availability because of an increase in their surface area and saturation 
solubility [5, 6].  
Media milling is an efficient technique used to reduce the particle 
size of drugs to nanometer range and increase their water solubility. 
In this technique, the drug particles in aqueous suspension are size-
reduced by grinding using small and hard beads. The drug particle 
size is reduced by the attrition of drug particles with the grinding 
media. Nano-sized particles tend to form aggregates as a result of 
their large surface area. In order to minimize drug particle 
aggregation, it is necessary to stabilize drug particles using 
stabilizers, such as polymers and surfactants. The stabilizers adsorb 
on the surface of drug particles and stabilize the drug particles 
through ionic interactions [7]. Ziprasidone is a serotonin dopamine 
antagonist that works to treat the positive, negative and depressive 
symptoms associated with schizophrenia. The positive symptoms 
include visual and auditory hallucinations and delusions. The 
negative symptoms, which are harder to treat, include blunted affect, 
social withdrawal, and lack of motivation [8].  
The aim of this work was to prepare ZIP nanocrystals using a 
modified media milling method to increase its water solubility. In 
this work, we used a combination of sonication and media milling 
method for the preparation of ZIP nanocrystals. This combination 
reduced the processing time of media milling. The optimized 
nanocrystals of ZIP were characterized by particle size and size 
distribution, differential scanning calorimetry (DSC) and Fourier 
transform infrared (FTIR) spectroscopy. 
MATERIALS AND MEHODS 
Ziprasidone and Tween 80 (polyoxyethylene sorbitan monooleate) 
were purchased from Sigma-Aldrich (St. Louis, MO, USA). Kollidone 
was purchased from Fluka (Germany). All other materials used were 
of analytical grade. 
Preparation of ziprasidone nanocrystals 
For the preparation of stabilizer solution, Tween 80 was dissolved in 
purified water and then kollidone was added under mechanical 
agitation. Pure ZIP was dispersed into the stabilizer solution and kept 
under mechanical agitation. Once a uniform suspension was formed, 
the suspension was placed into a glass tube. Zirconium beads (two mm 
in diameter) were also placed into a glass tube. Nanocrystals were 
prepared after milling the suspension using zirconium beads. The 
tubes were shaken using an IKA® orbital shaker (Vibrax VXR Basic, 
Germany) with 1500 rpm at room temperature for 75 min. Then, 
milled suspension was sonicated using an ultrasonic bath at 37 °C for 
30 min. Different concentrations of stabilizers were tested in the 
preparation of the finest ZIP nanocrystals and then spray dried. The 
details about the formulation design are described in table 1. 
Evaluation 
Particle size  
Particle analysis was performed by using the Malvern instruments. 
Before measurement, the samples had to be diluted with de-ionized 
water to obtain a suitable concentration for measurement. Ten 
micro-liter of nanocrystals were diluted with 1 ml purified water [9]. 
Zeta potential (particle charge) 
Zeta potential was determine using Malvern Zeta Sizer to estimate 
the physical stability of nano suspension. The sampleswere 
prepared using de-ionized water with conductivity adjusted by 
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addition of sodium chloride before measurement. All measurements 
were performed in triplicate [10]. 
Differential scanning calorimetry (DSC) 
Thermal properties of ZIP and ZIP nanocrystals were analyzed using a 
DSC-1 (Mettler Toledo, Switzerland). Approximately, 5 mg of samples 
was placed in aluminum pans. The measurements were carried out at 
temperatures from 20 °C to 250 °C at a scan rate of 20 °C/min. 
Scanning electron microscope (SEM) 
The Nanocrystals were examined under a Scanning Electron 
Microscope. The morphology of the Ziprosidone Nanocrystals was 
examined by scanning electron microscopy (JSM 6390 India). The 
sample was mounted on an aluminum stub and sputter-coated for 120 
s with platinum particles in an argon atmosphere. The coated samples 
were then scanned, and the image was analyzed at 500 or 1000 axis. 
Fourier transforms infrared 
Pure ZIP, Pure ZIP with kollidone, Pure ZIP with tween and ZIP 
nanocrystals was diluted with potassium bromide and made into 
pellets. The FTIR spectra of samples were recorded using an FTIR 
spectrometer. 
Determination of solubility for ziprasidone (ZIP) and ZIP 
nanocystals  
The aqueous solubility of ZIP and ZIP nanocrystals was determined 
by a shake-flask method. Briefly, an excess amount of ZIP and dried 
ZIP nanocrystals were suspended in 9 ml of phosphate buffer pH 7.5, 
and the suspensions were shaken at 37 °C. Aliquots of solutions 
were withdrawn and filtered through a 0.22 μm whatman filter. The 
concentration of ZIP was determined in filtrates using Thermo 
UV/Visible Spectrophotometer (Genesys, USA) at 276 nm [15]. 
 
Table 1: Formulation design of ZIP nanocrystals using different concentrations of stabilizers 
Formulation Ziprasidone (g) Tween (g) Kollidone (g) Water (ml) 
F1 1.6 1.6 1.6 65 
F2 4 4 4 100 
F3 4 2 2 115 
F4 4 4 8 115 
F5 4 4 4 115 
 
 
Fig. 1: Pure ziprasidone and ziprasidone nanocrytals 
 
In vitro drug release studies 
In vitro drug release studies were performed into USP Type 2 
dissolution apparatus (Electrolab, India) using basket method at 
rotation of 75 rpm. The dissolution was carried in acid media. The 
volume and temperature of the dissolution medium were 900 ml 
and 37±0.2 °C, respectively. The samples were withdrawn at fixed 
times and were filtered and assayed through ultraviolet absorbance 
determination at 315 nm using a UV–visible spectrophotometer. The 
mean result of triplicate measurements, and the standard deviation 
wasreported [13]. 
RESULTS 
As shown in table 1, several formulations of ZIP nanocrystals were 
prepared using different concentrations of Tween 80 and kollidone 
as stabilizers. Drug concentration was fixed at 0.5%.  
Particle size 
Among the different concentrations of stabilizers, the finest ZIP 
nanocrystals (F2) were obtained by 4 g kollidone and 4 g Tween 80. 
Particle size of F2 was 238.2±2.5 nm. 
Zeta potential  
Zeta potential of F2 was found to be 0.465±0.05 mv  
Differential scanning calorimetry (DSC)  
Fig.4 and Fig.5 show DSC thermo-grams of pure ZIP and the finest ZIP 
nanocrystals [F2] respectively. The pure ZIP showed a typical 
endothermic peak at 60.910c, which corresponds to its melting point and 
the finest ZIP nanocrystals[F2] showed an endothermic peak at 55.80
 
c. 
Scanning electron microscopy 
The SEM image of the ziprasidone nanocrystals revealed that the 
particles are crystalline in shape.(Fig.1 and 3). The average size of 
the Ziprasidone nanocrystals was found to be less than 300 nm. 
 
Fig. 2: particle size of prepared ziprasidone nanocrystals 
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Fig. 3: SEM image of the ziprasodone (ZIP) nanocrystals 
Fourier transform infrared 
The molecular states of ZIP and the finest ZIP nanocrystals (F2) 
were investigated using FTIR. fig. 5 shows the FTIR spectrum of the 
ZIP and the dried finest ZIP nanocrystals (F2) in the range of 400-
4000 cm −1
The spectrum of the dried finest ZIP nanocrystals (F2) as shown in 
Fig.6, show no obvious difference with the ZIP spectra in the whole 
area of ZIP absorption bands. 
.  
Solubility for ziprasidone (ZIP) and ZIP nanocrystals 
The solubility of ZIP in buffer was 1.0±0.01 μg/ml while the solubility 
of ZIP from the dried finest ZIP nanocrystals (F2) was 8.2±0.03 μg/ml. 
Therefore, solubilty of the dried finest ZIP NC (F2) was found to be 
almost 8 times higher , as compared to that of the parent ZIP. 
 
 
Fig. 4: Differential scanning calorimetry thermo-gram of bulk ZIP powder 
 
 
Fig. 5: Differential scanning calorimetry thermo-gram of the finest Ziprasidone (ZIP) nanocrystals (F2) 
 
DISCUSSION 
Recently, the media milling technology is successfully used for the 
formulation of poorly water soluble drugs. The nano-sized drug 
particles prepared by media milling technique can improve the 
solubility and bio-availability of these drugs [12,13]. However, the 
main drawback of this technique is its longer processing time [14]. 
Many researchers have attempted to reduce the processing time by 
different strategies. For example, drug particle size reduction using a 
jet mill before media milling process can reduce the processing time 
of media milling [15]. The new combinational methods have also 
been developed for particle size reduction. These combinational 
methods can overcome the limitations of conventional size particle 
size reduction technologies and reduce the drug nanocrystals 
production time. In this study, we have used sonication to reduce the 
processing time of media milling for the preparation of ZIP 
nanocrystals. We have already prepared ZIP nanocrystals (mean 
particle size: 245±12 nm) by media milling method using Tween 80 
and kollidone as stabilizers after 24 h milling time. The use of 
sonication after media milling process has also reduced the milling 
time from 24 h to 75 min. As shown in table 1, the finest ZIP 
nanocrystals have (F2) shown mean particle size of 238.2±2.5 nm.  
The zeta potential of the finest ZIP nanocrystals (F2) is around-20 
mV, which is enough for sufficient electrostatic stabilization of ZIP 
nanocrystals. [16]. The morphology and size of the finest ZIP 
nanocrystals (F2) have been evaluated by SEM. DSC technique to 
investigate the effect of stabilizers on the ZIP structure. Comparing 
the DSC thermograms of ZIP and ZIP nanocrystals, no significant 
differences has been found between ZIP and the finest ZIP 
nanocrystals (F2) curves. It has been concluded that there was no 
interaction between ZIP and stabilizers. The shift of ZIP peak in the 
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ZIP nanocrystals sample to the lower temperature can be due to the 
presence of Tween 80 on the surface of ZIP nanocrystal [7]. The 
FTIR spectra of pure ZIP and ZIP nanocrystals have confirmed the 
presence of ZIP in the ZIP nanocrystals. Moreover, from the results 
of FTIR study, it can be concluded that there is no evidence of 
chemical interaction between ZIP and stabilizers. During solubility 
study, it has been observed that the solubility ZIP nanocrystals has 




Fig. 6: (a) FTIR of ZIP alone (b) FTIR of ZIP with tween (c) FTIR of ZIP with kollidone (d) FTIR of ZIP nanocrystals 
 
In vitro drug dissolution  
The results of the in vitro drug dissolution studies have been depicted in Table 2 and Fig.7. 
 
Table 2: In vitro drug release from prepared ZIP nanocrystals capsules (sample size =3 for each formulation) 
Formulation 10 min 15 min 20 min 30 min 45 min 60 min 
F1 28±2.1 46±2.6 61±2.6 82±2.5 92±2.2  97±2.1 
F2 19±2.5 24±2.3 37±2.5 53±2.2 64±2.5 81±2.0 
F3 23±2.3 47±2.4 50±2.0 80±2.4 97±2.2 100±2.3 
F4 18±2.1 29±2.1 40±2.2 59±2.7 67±2.5 95±2.5 
F5 15±2.4 26±2.6 49±2.6 67±2.2 75±2.3 99±2.4 
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Fig. 7: In vitro dissolution profile of prepared ZIP nanocrystals 
capsules (sample size =3 for each formulation) 
 
CONCLUSION 
In this study, nanocrystals of a poorly soluble drug ZIP were 
prepared easily using a combination of wet milling method and 
sonication. These nanocrystals could be used for the preparation of a 
promising new drug formulation of ZIP. Solubility study showed that 
ZIP nanocrystals gave higher solubility as compared to pure ZIP. 
Consequently, The ZIP nanocrystals could be a promising alternative 
drug delivery system to improve the bio-availability of ZIP. 
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